Matt Kaeberlein
Matt Kaeberlein is a professor at the University of Washington and a co-founder of the Dog Aging Project, the largest study of canine health and aging ever undertaken. His research focuses on understanding how genetics, lifestyle, and environmental factors influence the longevity and health of dogs, with the aim of extending their lifespan and improving their quality of life. Kaeberlein is also involved in clinical trials testing the potential anti-aging drug rapamycin on dogs, seeking to discover ways to slow down the aging process in pets.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Australia:
Matt Kaeberlein is the co-founder of the Dog Aging Project and explains the components of the study.
7